Paid Clinical Trials for Endometrial Cancer

Showing 21 – 40 of 61 results

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

by CTG

in Breast Cancer, Cervical Cancer, Endometrial Cancer, Colorectal Cancer, Bladder Cancer

Other

Wisconsin

Deadline:

12/01/2026

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

by CTG

in Endometrial Cancer

Other

Alabama

Deadline:

01/10/2028

Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)

by CTG

in Breast Cancer, Ovarian Cancer, Endometrial Cancer, Bladder Cancer, Colon Cancer

Other

California

Deadline:

12/31/2027

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

by CTG

in Endometrial Cancer, Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases, Fibrolamellar Carcinoma

Other

Arizona

Deadline:

12/01/2027

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

by CTG

in Breast Cancer, Ovarian Cancer, Endometrial Cancer, Squamous Non-small Cell Lung Cancer, Biliary Tract Carcinoma

Other

California

Deadline:

09/29/2027

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

by CTG

in Breast Cancer, Ovarian Cancer, Endometrial Cancer, Prostate Cancer, Advanced or Metastatic Solid Tumors

Other

Arizona

Deadline:

05/01/2027

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

by CTG

in Endometrial Cancer

Other

California

Deadline:

10/01/2027

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

by CTG

in Endometrial Cancer, Carcinoma, Gynecologic Cancer, Uterine Cancer

Other

Alabama

Deadline:

04/01/2027

RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer

by CTG

in Ovarian Cancer, Endometrial Cancer

Other

Massachusetts

Deadline:

08/01/2031

ASk Questions in GYnecologic Oncology (ASQ-GYO)

by CTG

in Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Vulvar Cancer, Vaginal Cancer

Other

Michigan

Deadline:

05/01/2028

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

by CTG

in Endometrial Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, High Grade Serous Ovarian Cancer, High Grade Epithelial Ovarian Cancer

Other

Arizona

Deadline:

10/01/2027

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

by CTG

in Endometrial Cancer, Near Infrared Fluorescence Imaging, CYTALUX (Pafolacianine) Injection, Planned Diagnostic Laparoscopies

Other

Pennsylvania

Deadline:

02/01/2029

DESTINY-PANTUMOUR04

by CTG

in Cervical Cancer, Endometrial Cancer, Bladder Cancer, Anal Cancer, Adenocarcinoma (NOS)

Other

Alabama

Deadline:

03/30/2028

Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

by CTG

in Endometrial Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Cutaneous Melanoma

Other

California

Deadline:

01/01/2027

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

by CTG

in Endometrial Cancer

Other

New Jersey

Deadline:

11/01/2027

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

by CTG

in Endometrial Cancer

Other

Arizona

Deadline:

02/19/2031

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

by CTG

in Endometrial Cancer

Other

Alabama

Deadline:

09/01/2026

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

by CTG

in Breast Cancer, Ovarian Cancer, Endometrial Cancer, Head and Neck Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma

Other

Florida

Deadline:

02/28/2029

MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer

by CTG

in Endometrial Cancer

Other

Kentucky

Deadline:

01/01/2030

Study of EV for Recurrent Endometrial Carcinoma

by CTG

in Endometrial Cancer

Other

Wisconsin

Deadline:

05/31/2028

Load more All clinical trials loaded.

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

DESTINY-PANTUMOUR04

Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer

Study of EV for Recurrent Endometrial Carcinoma

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Endometrial Cancer

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps